Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSThe U.S. Food and Drug Administration (FDA) guidance on real-world evidence (RWE) underscores the need for early engagement with the Agency to discuss real-world data (RWD) sources and non-interventional study designs prior to regulatory submission.
Join us for this webinar when we will explore how a robust and multidisciplinary feasibility methodology can de-risk regulatory and scientific strategy for external comparator studies. We will discuss key considerations for conducting feasibility assessment for external comparators utilizing RWD for regulatory submission, and strengthen understanding of these concepts through illustrative case studies.
Leanne Li, MPH, MBA
Sr. Principal, Regulatory Science & Study Innovation, IQVIA
Mayank Raizada, MS
Principal, Regulatory Science & Study Innovation, IQVIA
Julien Heidt, MS
Sr. Consultant, Regulatory Science & Study Innovation, IQVIA
Dony Patel, PhD
Director, Global Database Studies, IQVIA
Meet your clinical, economic, and regulatory needs throughout a product's lifecycle using U.S. real world solutions.